TrialBreast cancer research and treatment2026

A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis.

Antonio Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.